Acorai
PrivateLast Round
VC Round
Nov 27, 2024
Total Funding Raised
$6.96M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Acorai operates in Healthcare & Life Sciences and is based in Helsingborg. Its latest recorded funding round was a VC Round in November 2024.
Acorai is a medical technology company developing a non-invasive device for cardiac and pulmonary pressure sensing to help manage heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acorai Comparables
Compare Acorai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensydia | 83% | |
| Cardiosense | 83% | |
| CardioStory | 83% |
For institutional investors. Book with your work email.
Acorai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 27, 2024 | ||||
| Seed | Jan 22, 2024 | ||||
| Grant | Nov 8, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Acorai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Angels Investors | Seed |
| European Innovation Council Fund | Grant |
| Life Science Invest | Seed |
| Life Science Invest | Seed |
| Taipei Medical University | VC Round |
| CARMA FUND | Seed |
| Meridian Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 139% MoM, reaching 6.1K.
- Jul 26, 2026
Monthly visitors increased 32% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Acorai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acorai's valuation, stock price, and market status.
Is Acorai a public or private company?
Acorai is a private company.
What is the current stock price of Acorai?
Acorai is a private company, so its shares have no public market price. Caplight tracks Acorai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acorai worth (valuation)?
Valuation information for Acorai is not publicly available.
Can I buy Acorai stock?
Acorai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acorai's last funding round?
Acorai's most recent funding round was VC Round on November 27, 2024.
Who are the main investors in Acorai?
Key investors in Acorai include Golden Angels Investors, European Innovation Council Fund, Life Science Invest, Life Science Invest, Taipei Medical University.
Will Acorai IPO soon?
No public IPO plans have been announced for Acorai.
How can I track Acorai secondary market activity?
Caplight tracks bids, offers, and trades in Acorai's shares on secondary markets.